Hyderabad-based Anu's Laboratories has filed draft red herring prospectus with Sebi to raise around Rs 800 million from the capital markets.
Anu's Labs is the market leader in producing or DCFA, which is a key intermediate for ciprofloxacin (a synthetic antibiotic). The company has over 60% market share in the country.
The company plans to deploy the proceeds raised from the initial public offering to set up an intermediary plant and contract research facility at Pharma City at Visakhapatnam.
